1. ALEJANDRA VARGAS VELÁSQUEZMEDICINE STUDENTIII SEMESTER Teacher, LINA MARÍA MARTÍNEZ SÁNCHEZ BIOLOGY MOLECULAR FEBRAURY 27, 2012 MEDELLÍN, COLOMBIA 2. DNA RNA HealthI…

Slide 1Modeling Childhood-onset Myotonic Dystrophy Jordan Gladman Ph.D. PRPR 9/24/2012 Slide 2 Myotonic Dystrophy Type 1  Autosomal dominant  1 in 8000 - most common…

Slide 1 1 Effects of IPLEX in Myotonic Dystrophy Type 1 (DM1) Muscle Study Group Annual Meeting 9/16/2008, Beaver Hollow, NY Richard T. Moxley, III, MD Slide 2 2 University…

Research and development of new drugs for human diseases Valentia Biopharma - In vivo Drug Discovery Currently focused on finding lead compounds to achieve an effective treatment…

Myotonia Congenita Shannon L Venance, MD PhD ICNDM, Kansas City June 3, 2007 Disclosure Statement NIH: 8U54 NS059065 funding for the Consortium for Clinical Investigation…

Slide 1 Modeling Childhood-onset Myotonic Dystrophy Jordan Gladman Ph.D. PRPR 9/24/2012 Myotonic Dystrophy Type 1 Autosomal dominant 1 in 8000 - most common adult muscular…

Nemoci spojené s expanzí mikrosatelitních repetitivních sekvencí – myotonická dystrofie typu 1 Kongenitální myotonie a mutace v genu CLCN1  Half of the human…

Alopecia is a common finding in myotonic dystro- phy type 1 (MD1) but it is usually restricted to the fronto-temporal areas (frontal baldness).1-3 Alopecia also of other

130 Copyright © 2013 Korean Neurological Association Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2013.9.2.130 CASE REPORT J Clin Neurol

Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosisNeuroImage: Clinical 29 (2021) 102562 Available online